Codexis, Inc.
General ticker "CDXS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $183.0M (TTM average)
Codexis, Inc. follows the US Stock Market performance with the rate: 7.4%.
Estimated limits based on current volatility of 2.6%: low 2.66$, high 2.81$
Factors to consider:
- Total employees count: 188 (+8.0%) as of 2024
- China accounted for 16.5% of revenue in the fiscal year ended 2024-12-31
- US accounted for 35.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: History of net losses and potential unprofitability, Productivity and cost issues at facilities, Third-party risks, Labor/talent shortage/retention, Strategic risks and growth management
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.19$, 2.98$]
- 2026-12-31 to 2027-12-31 estimated range: [1.28$, 3.09$]
Financial Metrics affecting the CDXS estimates:
- Positive: with PPE of -3.2 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 16.40 > -0.60
- Positive: 19.24 < Shareholder equity ratio, % of 34.19 <= 42.59
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of -9.25 <= -0.75
Short-term CDXS quotes
Long-term CDXS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $70.14MM | $59.34MM | $70.39MM |
| Operating Expenses | $138.21MM | $117.86MM | $108.72MM |
| Operating Income | $-68.07MM | $-58.52MM | $-38.33MM |
| Non-Operating Income | $-8.10MM | $-6.72MM | $-5.59MM |
| R&D Expense | $58.88MM | $46.26MM | $52.31MM |
| Income(Loss) | $-76.17MM | $-65.24MM | $-43.93MM |
| Taxes | $0.07MM | $0.03MM | $0.05MM |
| Net Income(Loss)* | $-76.24MM | $-65.28MM | $-43.97MM |
| Stockholders Equity | $86.61MM | $66.93MM | $50.53MM |
| Inventory | $2.69MM | $1.80MM | $1.82MM |
| Assets | $136.56MM | $149.01MM | $147.80MM |
| Operating Cash Flow | $-52.64MM | $-49.41MM | $-19.38MM |
| Capital expenditure | $4.42MM | $4.30MM | $4.47MM |
| Investing Cash Flow | $-4.86MM | $-56.98MM | $23.50MM |
| Financing Cash Flow | $8.17MM | $60.52MM | $27.93MM |
| Earnings Per Share** | $-1.12 | $-0.89 | $-0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.